Amoxicillin trihydrate Chemical Properties

Melting point:

>200°C (dec.)

alpha 

D20 +246° (c = 0.1)

refractive index 

302 ° (C=0.1, H2O)

storage temp. 

Inert atmosphere,2-8°C

solubility 

Slightly soluble in water, very slightly soluble in ethanol (96 per cent), practically insoluble in fatty oils. It dissolves in dilute acids and dilute solutions of alkali hydroxides.

form 

Solid

color 

White to Off-White

Water Solubility 

Soluble in water at 3.4mg/ml.

Merck 

14,577

JECFA Number

85

BRN 

7507120

CAS DataBase Reference

61336-70-7(CAS DataBase Reference)

EPA Substance Registry System

Amoxicillin trihydrate (61336-70-7)

Safety Information

Hazard Codes 

Xn,Xi

Risk Statements 

42/43

Safety Statements 

36-36/37-22

WGK Germany 

2

RTECS 

XH8300000

HS Code 

29411000

Toxicity

LD50 ipr-rat: 2870 mg/kg KSRNAM 7,3040,73

Amoxicillin trihydrate Usage And Synthesis

Description

Amoxicillin was synthesized by Beecham Research Laboratories in 1968. A hydroxyl group was introduced on the benzene ring of ampicillin. Amoxicillin shows about a twofold higher serum concentration than ampicillin when administered orally. It was shown by double-blind comparative studies with ampicillin that amoxicillin was as effective as ampicillin when administered at half the dose of ampicillin.

Chemical Properties

White to Off-White Solid

Originator

Arnoxil,Bencard,UK,1972

Uses

Semi-synthetic antibiotic related to Penicillin. Antibacterial.

Uses

Amoxicillin trihydratesemi-synthetic antibiotic related to Penicillin which has antibacterial poperties. It is used for treatment of a variety of bacterial infections. It is used as a pharmaceutical product as a antibiotic agent, anti-infective drug raw materials.

Definition

ChEBI: A hydrate that is the trihydrate form of amoxicillin; a semisynthetic antibiotic, used either alone or in combination with potassium clavulanate (under the trade name Augmentin) for treatment of a variety of bacterial infections.

Manufacturing Process

Ethyl chlorocarbonate (2.2 ml) was added to an ice cold solution of O,N-dibenzyloxycarbonyl-p-oxy-dl-α-aminophenylacetic acid (10 grams) and triethylamine (3.85 ml) in dry acetone (193 ml). The mixture was stirred at 0°C for 5 minutes during which triethylamine hydrochloride precipitated. The suspension was cooled to -30°C and stirred vigorously while adding as rapidly as possible an ice cold solution of 6-aminopenicillanic acid (5.85 grams) in 3% aqueous sodium bicarbonate (193 ml), the temperature of the mixture never being allowed to rise above 0°C. The resulting clear solution was stirred for 30 minutes at 0°C, and then for a further 30 minutes, without external cooling, and finally extracted with diethyl ether (3 x 200 ml) only the aqueous phase being retained.
This aqueous solution was brought to pH 2 by the addition of hydrochloric acid and the 6-(O,N-dibenzyloxycarbonyl-p-oxy-dl-α- aminophenylacetamido)penicillanic acid so liberated was extracted into diethyl ether (50 ml and 2 portions of 30 ml). The ether phase was washed with water (3 x 5 ml) and the water washings were discarded.
Finally, the penicillin was converted to the sodium salt by shaking the ether solution with sufficient 3% sodium bicarbonate to give a neutral aqueous phase, separating the latter and evaporating it at low pressure and temperature below 20°C. The product was finally dried over phosphorus pentoxide in vacuo to give sodium 6-(O,N-dibenzyloxycarbonyl-p-oxy-dl-α- aminophenylacetamido)-penicillanate (9.2 grams).
A suspension of palladium on calcium carbonate (36 grams of 5%) in water (150 ml) was shaken in an atmosphere of hydrogen at room temperature and atmospheric pressure for 1 hour. A neutral solution of sodium 6-(O,Ndibenzyloxycarbonyl- p-oxy-dl-α-aminophenylacetamido)penicillanate (9 grams) in water (100 ml) was then added and shaking in hydrogen was resumed for one hour. The suspension was then filtered and the collected catalyst was washed well with water without being allowed to suck dry between washings. The combined filtrate and washings were then brought to pH 6.5 with dilute hydrochloric acid and evaporated to dryness at reduced pressure and temperatures below 20°C. The product was finally dried over phosphorus pentoxide in vacuo to give a solid (5.4 grams) containing 6-(phydroxy- dl-α-aminophenylacetamido)penicillanic acid.

brand name

Amoxil (GlaxoSmithKline); Dispermox (Ranbaxy); Larotid (GlaxoSmithKline); Trimox (Apothecon) [Name previously used: Amoxycillin.].

Therapeutic Function

Antibacterial

Contact allergens

Amoxicillin is both a topical and a systemic sensitizer. Topical sensitization occurs in health care workers. Systemic drug reactions are frequent, such as urticaria, maculo-papular rashes, baboon syndrome, acute generalized exanthematous pustulosis, or even toxic epidermal necrosis. Cross-reactivity is common with ampicillin, and can occur with other penicillins.

Safety Profile

Moderately toxic. An experimental teratogen. Other experimental reproductive effects. When heated to decomposition it emits toxic fumes of SOx and NOx.

Amoxicillin trihydrate(61336-70-7)Related Product Information

• Dimethyl carbonate
• Dimethyl ether
• Dimethyl sebacate
• Dimethyl sulfide
• Chlorodimethylphenylsilane
• N,N-Dimethyl-1,4-phenylenediamine
• Ampicillin
• Ampicillin sodium
• Dimethyl sulfoxide
• Dimethyl sulfate
• ETHANE
• Dimethyl fumarate
• N,N-Dimethylformamide
• AMOXICILLIN TRIHYDRATE IMP. I (EP): (2R)-2-AMINO-2-(4-HYDROXYPHENYL)ACETIC ACID
• AMOXICILLIN TRIHYDRATE(FOR SUSPENSION.)
• Amoxicillin trihydrate for direct compression
• Penicillin G
• Ampicillin